The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.
The Three Pillars of LLS’ mission: Research, Advocacy, and Access
Research: LLS has invested $1.2 billion in cutting-edge research, funding nearly all of today’s most promising advances.
Access: LLS has provided free information, support services, and financial assistance to over 30,000 people last year.
Advocacy: LLS’ network of more than 100,000 volunteers advocate for state and federal policies that benefit patients ..
Since 2000 more than 40% of the new cancer therapies approved by the FDA are for blood cancer
Blood cancer research leads to treatment advances for other cancers and serious diseases
LLS funded more than 60% of those therapies
LLS funded 15 OF 18 FDA approved treatments in 2017
LLS supported 227 research grants, a $211 million multi-year commitment in 2017